Intrepid Capital Management Inc. Has $289,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Intrepid Capital Management Inc. increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 572 shares of the healthcare conglomerate’s stock after buying an additional 44 shares during the quarter. Intrepid Capital Management Inc.’s holdings in UnitedHealth Group were worth $289,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $32,000. Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $40,000. Finally, DecisionPoint Financial LLC lifted its holdings in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Stephens upped their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $522.97 on Wednesday. The stock’s fifty day simple moving average is $509.06 and its two-hundred day simple moving average is $542.96. The stock has a market cap of $478.37 billion, a PE ratio of 33.74, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.